PapersFlow Research Brief
DNA Repair Mechanisms
Research Guide
What is DNA Repair Mechanisms?
DNA repair mechanisms are the cellular pathways that detect DNA lesions, coordinate damage signaling and cell-cycle control, and restore DNA sequence and chromosome integrity to limit mutation and genomic instability.
Across the literature indexed under this topic, there are 118,732 works addressing how DNA damage is sensed, signaled, and repaired, and how repair failure contributes to mutation accumulation and disease. "Signatures of mutational processes in human cancer" (2013) established that characteristic mutation patterns in tumors can be interpreted as readouts of underlying DNA damage and repair processes. "p53 Mutations in Human Cancers" (1991) documented that p53 mutational spectra vary across cancer types, linking DNA damage responses and selection to tissue-specific carcinogenesis.
Research Sub-Topics
Base Excision Repair
This sub-topic studies the enzymatic removal and replacement of damaged or mismatched bases by glycosylases, AP endonucleases, and polymerases. Researchers focus on oxidative and alkylation damage pathways.
Nucleotide Excision Repair
This sub-topic investigates the recognition, incision, and resynthesis steps for bulky helix-distorting lesions like UV-induced cyclobutane pyrimidine dimers. Researchers analyze xeroderma pigmentosum factors.
Mismatch Repair
This sub-topic examines MutS/MutL-mediated detection and excision of replication errors and insertion-deletion loops. Researchers study Lynch syndrome-associated genes MLH1 and MSH2.
Non-Homologous End Joining
This sub-topic dissects the Ku-DNA-PKcs-Ligase IV complex ligation of double-strand breaks without homology. Researchers probe error-prone joining and VDJ recombination.
Homologous Recombination Repair
This sub-topic explores RAD51-mediated strand invasion and error-free repair of double-strand breaks using sister chromatids. Researchers investigate BRCA1/2 roles and Fanconi anemia pathways.
Why It Matters
DNA repair mechanisms matter because they determine mutation burden, cancer evolution, and therapeutic vulnerability, and they shape how researchers measure and interpret DNA damage in cells and genomes. In oncology, "The Hallmarks of Cancer" (2000) framed genomic instability as a core enabling characteristic of cancer, providing a conceptual anchor for why defects in repair and damage checkpoints are clinically consequential. In tumor genomics, Alexandrov et al. (2013) in "Signatures of mutational processes in human cancer" showed that mutational signatures can be used to infer operative mutational processes in human cancers, enabling practical workflows where sequencing data are translated into hypotheses about DNA damage and repair deficiencies. In laboratory and clinical practice, foundational methods support repair research and its applications: Miller et al. (1988) in "A simple salting out procedure for extracting DNA from human nucleated cells" described a widely used DNA extraction approach that underpins downstream assays of DNA damage and repair; Church and Gilbert (1984) in "Genomic sequencing." described direct determination of unique DNA sequences from genomic DNA, supporting genome-wide detection of mutation patterns that can reflect repair defects. In genetic toxicology, Maron and Ames (1983) in "Revised methods for the Salmonella mutagenicity test" standardized mutagenicity testing that is frequently used to evaluate DNA-damaging agents whose lesions engage specific repair pathways. In translational biotech news, reports on Seamless Therapeutics’ recombinase platform emphasized precise DNA insertions “independently of cellular DNA repair mechanisms,” highlighting a concrete engineering motivation: avoiding endogenous repair outcomes that can be heterogeneous and difficult to control (Seamless/Eli Lilly deal reported as up to $1.1B and separately as $1.12 billion).
Reading Guide
Where to Start
Start with "The Hallmarks of Cancer" (2000) because it provides the organizing rationale for why genome maintenance and genomic instability are central to disease, motivating why DNA repair mechanisms are studied and targeted.
Key Papers Explained
Conceptually, "The Hallmarks of Cancer" (2000) motivates why DNA damage responses and repair matter for tumorigenesis. Mechanistically and interpretively, Alexandrov et al. (2013) in "Signatures of mutational processes in human cancer" provides a genome-scale way to read out the consequences of damage and repair through mutation patterns, while Hollstein et al. (1991) in "p53 Mutations in Human Cancers" provides a gene-centered view of how mutational spectra vary across tissues and cancers. For physical context, Luger et al. (1997) in "Crystal structure of the nucleosome core particle at 2.8 Å resolution" frames repair as a chromatin problem, not only a DNA chemistry problem. For practical workflows, Miller et al. (1988) in "A simple salting out procedure for extracting DNA from human nucleated cells" and Church and Gilbert (1984) in "Genomic sequencing." anchor the sample-to-sequence pipeline that enables mutation-based inference of repair activity.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
A current applied direction highlighted in recent news is to bypass endogenous DNA repair outcomes during genome modification: reports on Seamless Therapeutics’ recombinase platform stress large, precise insertions “independent of the cell’s natural DNA repair mechanisms,” reflecting a push to avoid heterogeneous repair-mediated outcomes in genetic medicine development (Seamless/Eli Lilly deal reported as up to $1.1B and as $1.12 billion). In parallel, cancer-focused efforts continue to operationalize mutation patterns and DNA damage response vulnerabilities, building on the interpretive logic of "Signatures of mutational processes in human cancer" (2013) and the disease framing of "The Hallmarks of Cancer" (2000).
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | The Hallmarks of Cancer | 2000 | Cell | 28.3K | ✓ |
| 2 | A simple salting out procedure for extracting DNA from human n... | 1988 | Nucleic Acids Research | 20.4K | ✓ |
| 3 | Signatures of mutational processes in human cancer | 2013 | Nature | 9.9K | ✓ |
| 4 | Crystal structure of the nucleosome core particle at 2.8 Å res... | 1997 | Nature | 9.3K | ✕ |
| 5 | A Film Detection Method for Tritium‐Labelled Proteins and Nucl... | 1974 | European Journal of Bi... | 8.6K | ✓ |
| 6 | Genomic sequencing. | 1984 | Proceedings of the Nat... | 8.2K | ✓ |
| 7 | Interpreting chromosomal DNA restriction patterns produced by ... | 1995 | Journal of Clinical Mi... | 8.2K | ✓ |
| 8 | p53 Mutations in Human Cancers | 1991 | Science | 8.1K | ✕ |
| 9 | Transformation of intact yeast cells treated with alkali cations | 1983 | Journal of Bacteriology | 7.7K | ✓ |
| 10 | Revised methods for the Salmonella mutagenicity test | 1983 | Mutation Research/Envi... | 7.3K | ✕ |
In the News
Dresden biotech Seamless lands up to $1.1B Eli Lilly deal ...
As part of the collaboration, Seamless contributes its proprietary recombinase platform, which enables precise and large-scale DNA insertions and modifications independently of cellular DNA repair ...
Seamless Therapeutics Enters $1.12 Billion Global ...
* Seamless Therapeutics and Eli Lilly collaborate to develop genetic medicines for hearing loss using recombinase technology. * The recombinase platform enables precise DNA insertions without relyi...
Eli Lilly partners with Seamless Therapeutics on gene ...
The collaboration will use Seamless’ proprietary recombinase platform, which enables large, precise DNA insertions independent of the cell’s natural DNA repair mechanisms.
Swiss BioTech FoRx Therapeutics closes €42 million for ...
Basel-based **FoRx Therapeutics** , a clinical-stage BioTech company developing precision anti-cancer therapeutics, today announced the close of an insider-led €42 million ($50 million) Series A fi...
A 'DNA damage repair' drugmaker raises $115M for cancer ...
Emerging biotech # A ‘DNA damage repair’ drugmaker raises $115M for cancer treatments
Code & Tools
Apindel is a deep learning framework based on Attention mechanism and Positional Encoding for predicting CRISPR/Cas9 repair outcomes.
- **final**: result from paper - **SNMF**: containing all the code for the SNMF model, adapted from the SigProfiler framework - **src**: containin...
Reference implementation of RepairSig, a computational approach that accounts for the non-additivity of DNA damage and repair processes by modeling...
## Repository files navigation # LoopExtrusion Loop extrusion as a mechanism for DNA Double-Strand Breaks repair foci formation ## Overview
CRISPR-induced cut. inDelphi synthesizes known biological mechanisms of DNA repair with machine learning and achieves strong accuracy.
Recent Preprints
(PDF) Mechanisms of DNA damage, repair, and mutagenesis
... DNA is prone to chemical changes due to internal and external agents, and errors made by DNA polymerases during replication can cause mutations. However, cells have complex DNA repair mechanism...
Targeting DNA Damage Response and Immune Crosstalk ...
Cancer progression and therapeutic resistance are driven by complex molecular interactions between genomic instability and immune modulation. Defects in the DNA damage response (DDR) not only promo...
DNA repair and genetic instability
• Environmental exposures and reactive species generated during normal cellular processes can damage DNA, which can lead to genetic instability. DNA damage repair and signalling pathways operate to...
How Cells Repair DNA Damage
Advances in molecular biology, genomics, and gene editing have opened new frontiers in understanding and manipulating DNA repair. Techniques like CRISPR-Cas9 not only allow us to study repair mecha...
DNA Damage and Repair - Recent articles and discoveries
Uncover the latest and most impactful research in DNA Damage and Repair. Explore pioneering discoveries, insightful ideas and new methods from leading researchers in the field. ## Latest research
Latest Developments
Recent developments in DNA repair mechanisms research include findings on how a broken DNA repair tool accelerates aging, as of January 30, 2026 (Phys.org), insights into hierarchical mechanisms controlling DNA lesion clearance from Nature on January 22, 2026 (Nature), and discoveries about how certain tumors survive DNA damage by activating backup repair pathways, published by Scripps Research on December 3, 2025 (Scripps Research).
Sources
Frequently Asked Questions
What are DNA repair mechanisms in practical experimental terms?
DNA repair mechanisms are the cellular processes that recognize DNA damage, signal its presence, and enzymatically restore DNA to preserve genome integrity. Their activity is often inferred from mutation patterns in genomes, as shown by Alexandrov et al. (2013) in "Signatures of mutational processes in human cancer."
How do researchers connect DNA repair defects to observed mutations in cancer genomes?
A common approach is to interpret recurring mutation patterns as signatures of underlying mutational processes that include DNA damage and repair components. Alexandrov et al. (2013) in "Signatures of mutational processes in human cancer" demonstrated that such signatures can be extracted and interpreted from human cancer data.
Why is p53 frequently discussed alongside DNA damage responses and repair?
p53 is a tumor suppressor whose mutation patterns differ by cancer type, reflecting differences in mutagen exposure, damage processing, and selection. Hollstein et al. (1991) in "p53 Mutations in Human Cancers" reported that p53 mutational spectra vary among cancers of multiple tissues, supporting its use as a lens on DNA damage and response pathways.
Which foundational methods enable measurement of DNA damage, repair, and mutagenesis?
Core enabling methods include robust DNA extraction and genome-level readouts of sequence change. Miller et al. (1988) in "A simple salting out procedure for extracting DNA from human nucleated cells" provided a practical extraction protocol, and Church and Gilbert (1984) in "Genomic sequencing." described determining unique DNA sequences directly from genomic DNA, supporting mutation detection relevant to repair studies.
How are DNA-damaging agents and repair-relevant mutagenicity assessed in standard assays?
Mutagenicity tests provide standardized ways to quantify mutation induction by exposures that create DNA lesions handled by repair systems. Maron and Ames (1983) in "Revised methods for the Salmonella mutagenicity test" described revised procedures that are widely used to evaluate mutagenic potential.
Which papers in the provided list are most directly useful for interpreting DNA repair through chromatin and genome organization?
Chromatin structure constrains access of repair factors to DNA and influences lesion processing. Luger et al. (1997) in "Crystal structure of the nucleosome core particle at 2.8 Å resolution" provided structural context for how DNA is packaged, which is essential background for mechanistic thinking about repair in chromatin.
Open Research Questions
- ? How can mutational-signature frameworks like those in "Signatures of mutational processes in human cancer" (2013) be mapped unambiguously to specific DNA repair pathways rather than to mixtures of damage sources and downstream processing?
- ? Which mechanisms explain the tissue-specific differences in p53 mutational spectra reported in "p53 Mutations in Human Cancers" (1991), and how much is attributable to exposure versus repair pathway usage versus selection?
- ? How does nucleosome organization described in "Crystal structure of the nucleosome core particle at 2.8 Å resolution" (1997) quantitatively alter lesion accessibility and repair outcomes across the genome?
- ? Which experimental designs best connect standardized mutagenicity outcomes from "Revised methods for the Salmonella mutagenicity test" (1983) to genome-wide mutation patterns used in signature analyses?
- ? To what extent can engineered genome modification strategies that operate independently of endogenous repair (as described in news coverage of recombinase platforms) reduce unintended mutational outcomes compared with repair-dependent editing approaches?
Recent Trends
The topic is large (118,732 works), and recent emphasis in the provided materials is on translating DNA damage/repair knowledge into genome-scale interpretation and therapeutic engineering.
Genome-based inference remains anchored by Alexandrov et al. in "Signatures of mutational processes in human cancer," while disease relevance is repeatedly framed through "The Hallmarks of Cancer" (2000) and tissue-specific mutation patterns such as those summarized in "p53 Mutations in Human Cancers" (1991).
2013In the past year’s news coverage, a notable applied trend is engineering DNA modification methods that explicitly avoid endogenous repair pathways, exemplified by reports describing recombinase-based insertion platforms and the associated Seamless–Eli Lilly collaboration (reported as up to $1.1B and as $1.12 billion).
Research DNA Repair Mechanisms with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching DNA Repair Mechanisms with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.